These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17694307)

  • 1. A new PET tracer specific for vascular endothelial growth factor receptor 2.
    Wang H; Cai W; Chen K; Li ZB; Kashefi A; He L; Chen X
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2001-10. PubMed ID: 17694307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET of vascular endothelial growth factor receptor expression.
    Cai W; Chen K; Mohamedali KA; Cao Q; Gambhir SS; Rosenblum MG; Chen X
    J Nucl Med; 2006 Dec; 47(12):2048-56. PubMed ID: 17138749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants.
    Meyer JP; Edwards KJ; Kozlowski P; Backer MV; Backer JM; Lewis JS
    J Nucl Med; 2016 Nov; 57(11):1811-1816. PubMed ID: 27390161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative PET imaging of VEGF receptor expression.
    Chen K; Cai W; Li ZB; Wang H; Chen X
    Mol Imaging Biol; 2009; 11(1):15-22. PubMed ID: 18784964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptor.
    Li F; Jiang S; Zu Y; Lee DY; Li Z
    J Nucl Med; 2014 Sep; 55(9):1525-31. PubMed ID: 24970912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice.
    Cai W; Ebrahimnejad A; Chen K; Cao Q; Li ZB; Tice DA; Chen X
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2024-36. PubMed ID: 17673999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography imaging of poststroke angiogenesis.
    Cai W; Guzman R; Hsu AR; Wang H; Chen K; Sun G; Gera A; Choi R; Bliss T; He L; Li ZB; Maag AL; Hori N; Zhao H; Moseley M; Steinberg GK; Chen X
    Stroke; 2009 Jan; 40(1):270-7. PubMed ID: 18948613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.
    Luo H; England CG; Graves SA; Sun H; Liu G; Nickles RJ; Cai W
    J Nucl Med; 2016 Feb; 57(2):285-90. PubMed ID: 26541778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121.
    Zhang Y; Hong H; Niu G; Valdovinos HF; Orbay H; Nayak TR; Chen X; Barnhart TE; Cai W
    Mol Pharm; 2012 Dec; 9(12):3586-94. PubMed ID: 23137334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A vascular endothelial growth factor 121 (VEGF(121))-based dual PET/optical probe for in vivo imaging of VEGF receptor expression.
    Kang CM; Koo HJ; Lee KC; Choe YS; Choi JY; Lee KH; Kim BT
    Biomaterials; 2013 Sep; 34(28):6839-45. PubMed ID: 23787114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts.
    Paudyal B; Paudyal P; Oriuchi N; Hanaoka H; Tominaga H; Endo K
    Cancer Sci; 2011 Jan; 102(1):117-21. PubMed ID: 21070475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots.
    Chen K; Li ZB; Wang H; Cai W; Chen X
    Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2235-44. PubMed ID: 18566815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer.
    Liu Z; Li ZB; Cao Q; Liu S; Wang F; Chen X
    J Nucl Med; 2009 Jul; 50(7):1168-77. PubMed ID: 19525469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography imaging of CD105 expression during tumor angiogenesis.
    Hong H; Yang Y; Zhang Y; Engle JW; Barnhart TE; Nickles RJ; Leigh BR; Cai W
    Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1335-43. PubMed ID: 21373764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
    J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ⁶⁸Ga-NODAGA-VEGF₁₂₁ for in vivo imaging of VEGF receptor expression.
    Kang CM; Koo HJ; Choe YS; Choi JY; Lee KH; Kim BT
    Nucl Med Biol; 2014 Jan; 41(1):51-7. PubMed ID: 24183611
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.